关注
Marios Koutsakos
Marios Koutsakos
Peter Doherty Institute, University of Melbourne
在 student.unimelb.edu.au 的电子邮件经过验证
标题
引用次数
年份
Influenza B virus neuraminidase: a potential target for next-generation vaccines?
THT Do, AK Wheatley, SJ Kent, M Koutsakos
Expert Review of Vaccines 23 (1), 39-48, 2024
22024
Immune imprinting in early life shapes cross-reactivity to influenza B virus haemagglutinin
P Edler, LSU Schwab, M Aban, M Wille, N Spirason, YM Deng, ...
Nature Microbiology, 1-11, 2024
2024
Dissemination of influenza B virus to the lower respiratory tract of mice is restricted by the interferon response
LSU Schwab, THT Do, D Pilapitiya, M Koutsakos
Journal of Virology 98 (6), e01604-23, 2024
2024
Is eradication of influenza B viruses possible?
M Koutsakos, S Rockman, F Krammer
The Lancet. Infectious diseases 24 (5), 451-453, 2024
2024
Characterisation of novel influenza‐derived HLA‐B* 18: 01‐restricted epitopes
SL Leong, L Murdolo, JC Maddumage, M Koutsakos, K Kedzierska, ...
Clinical & Translational Immunology 13 (5), e1509, 2024
2024
Durable reprogramming of neutralizing antibody responses following Omicron breakthrough infection
WS Lee, HX Tan, A Reynaldi, R Esterbauer, M Koutsakos, J Nguyen, ...
Science Advances 9 (29), eadg5301, 2023
112023
Immunological imprinting: understanding COVID-19
M Koutsakos, AH Ellebedy
Immunity 56 (5), 909-913, 2023
372023
SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses
M Koutsakos, A Reynaldi, WS Lee, J Nguyen, T Amarasena, G Taiaroa, ...
Immunity 56 (4), 879-892. e4, 2023
582023
Prime-boost, double-dose influenza vaccine immunity in COPD: a pilot observational study
GP Anderson, LB Irving, A Jarnicki, K Kedzierska, M Koutsakos, S Kent, ...
ERJ Open Research 9 (2), 2023
12023
Differential cross-reactivity to the influenza B virus haemagglutinin underpins lineage-specific susceptibility between birth cohorts
P Edler, LSU Schwab, M Aban, M Wille, N Spirason, YM Deng, ...
bioRxiv, 2023.08. 25.554879, 2023
22023
Assessment of antibodies in the upper and lower human respiratory tract at steady state and after respiratory viral infection
M Koutsakos, JS Turner, MCV Guillamet, D Reynolds, T Lei, DE Byers, ...
Clinical & Translational Immunology 12 (8), e1460, 2023
22023
Robust immunity to influenza vaccination in haematopoietic stem cell transplant recipients following reconstitution of humoral and adaptive immunity
W Zhang, LC Rowntree, R Muttucumaru, T Damelang, M Aban, AC Hurt, ...
Clinical & Translational Immunology 12 (6), e1456, 2023
32023
Rapid recall andde novoT cell responses during SARS-CoV-2 breakthrough infection
M Koutsakos, A Reynaldi, WS Lee, J Nguyen, T Amarasena, G Taiaroa, ...
2022
Rapid recall and de novo T cell responses during SARS-CoV-2 breakthrough infection
M Koutsakos, A Reynaldi, WS Lee, J Nguyen, T Amarasena, G Taiaroa, ...
bioRxiv, 2022.12. 19.521129, 2022
12022
Methods and compositions for preventing influenza infection
M Koutsakos, K Kedzierska, EB CLEMENS, L Hensen
US Patent 11,517,617, 2022
2022
Immunization with inactivated whole virus particle influenza virus vaccines improves the humoral response landscape in cynomolgus macaques
BY Chua, T Sekiya, M Koutsakos, N Nomura, LC Rowntree, THO Nguyen, ...
PLoS pathogens 18 (10), e1010891, 2022
22022
SATB1 ensures appropriate transcriptional programs within naïve CD8+ T cells
S Nüssing, LA Miosge, K Lee, M Olshansky, A Barugahare, CM Roots, ...
Immunology and Cell Biology 100 (8), 636-652, 2022
52022
The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants
M Koutsakos, WS Lee, A Reynaldi, HX Tan, G Gare, P Kinsella, KC Liew, ...
Immunity 55 (7), 1316-1326. e4, 2022
432022
Long live the plasma cell: the basis of sustained humoral immunity
M Koutsakos, AH Ellebedy
The Journal of Immunology 209 (1), 3-4, 2022
22022
Establishment and recall of SARS-CoV-2 spike epitope-specific CD4+ T cell memory
KM Wragg, WS Lee, M Koutsakos, HX Tan, T Amarasena, A Reynaldi, ...
Nature Immunology 23 (5), 768-780, 2022
552022
系统目前无法执行此操作,请稍后再试。
文章 1–20